Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease

Por Busaidy, Naifa Lamki, Cabanillas, Maria E.
Publicado em 2012

Applying New Clinicopathologic Characteristics to Prognostication in Advanced Thyroid Carcinoma

Por Cabanillas, Maria E., Sherman, Steven I.
Publicado em 2012

The treatment landscape in thyroid cancer: a focus on cabozantinib

Por Weitzman, Steven P, Cabanillas, Maria E
Publicado no Cancer Manag Res (2015)

Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond

Por Rao, Sarika N, Cabanillas, Maria E
Publicado no J Endocr Soc (2018)

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond

Por Cabanillas, Maria E, Ryder, Mabel, Jimenez, Camilo
Publicado no Endocr Rev (2019)

In Reply

Por Cabanillas, Maria E., Dadu, Ramona, Lai, Stephen Y.
Publicado em 2014

Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat—and With Which Drug—Those Are the Questions

Por Cabanillas, Maria E., Hu, Mimi I., Jimenez, Camilo
Publicado no J Clin Endocrinol Metab (2014)

Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer

Por Cabanillas, Maria E., Hu, Mimi I., Durand, Jean-Bernard, Busaidy, Naifa L.
Publicado em 2011

Thyroid Oncology

Por M. Bugalho, Maria João, Wohllk, Nelson, Hoff, Ana O., Cabanillas, Maria E.
Publicado em 2011

A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer

Por Cabanillas, Maria E., Brose, Marcia S., Holland, Jaymes, Ferguson, Kimberly C., Sherman, Steven I.
Publicado em 2014

Treating medullary thyroid cancer in the age of targeted therapy

Por Cabanillas, Maria E, Hu, Mimi I, Jimenez, Camilo, Grubbs, Elizabeth G, Cote, Gilbert J
Publicado no Int J Endocr Oncol (2014)

Bilateral spontaneous pneumothoraces in anaplastic thyroid cancer

Por Kazzaz, Farah I., Cabanillas, Maria E., Bashoura, Lara, Shannon, Vickie R., Faiz, Saadia A.
Publicado no Respir Med Case Rep (2019)

Sorafenib in Metastatic Thyroid Cancer: A Systematic Review

Por Thomas, Ligy, Lai, Stephen Y., Dong, Wenli, Feng, Lei, Dadu, Ramona, Regone, Rachel M., Cabanillas, Maria E.
Publicado em 2014

Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer

Por Fabbro, Egidio Del, Dev, Rony, Cabanillas, Maria E., Busaidy, Naifa L., Rodriguez, EdenMae C., Bruera, Eduardo
Publicado em 2012

Aerodigestive Fistula Formation as a Rare Side Effect of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Thyroid Cancer

Por Blevins, Dean P., Dadu, Ramona, Hu, Mimi, Baik, Christina, Balachandran, Diwakar, Ross, William, Gunn, Brandon, Cabanillas, Maria E.
Publicado em 2014

Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model

Por Danysh, Brian P., Rieger, Erin Y., Sinha, Deepankar K., Evers, Caitlin V., Cote, Gilbert J., Cabanillas, Maria E., Hofmann, Marie-Claude
Publicado no Oncotarget (2016)

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, p...

Por Brose, Marcia S, Cabanillas, Maria E, Cohen, Ezra E W, Wirth, Lori J, Riehl, Todd, Yue, Huibin, Sherman, Prof Steven I, Sherman, Eric J
Publicado no Lancet Oncol (2016)

Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer–Related Diarrhea and Its Effects on Quality of Life: A Pilot Study

Por Dadu, Ramona, Hu, Mimi I., Cleeland, Charles, Busaidy, Naifa L., Habra, Mouhammed, Waguespack, Steven G., Sherman, Steven I., Ying, Anita, Fox, Patricia, Cabanillas, Maria E.
Publicado no Thyroid (2015)

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor–Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncolo...

Por Cabanillas, Maria E., de Souza, Jonas A., Geyer, Susan, Wirth, Lori J., Menefee, Michael E., Liu, Stephen V., Shah, Komal, Wright, John, Shah, Manisha H.
Publicado no J Clin Oncol (2017)

Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas

Por Hightower, Erica, Cabanillas, Maria E., Fuller, Greg N., McCutcheon, Ian E., Hess, Kenneth R., Shah, Komal, Waguespack, Steven G., Corley, Lynda J., Devin, Jessica K.
Publicado em 2012